Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis

Acta Derm Venereol. 2022 Aug 11:102:adv00755. doi: 10.2340/actadv.v102.685.

Authors

Marloes E Van Muijen¹, Sarah E Thomas, Douwe Vellinga, Silke Bouwman, Martijn B A Van Doorn, Klaziena Politiek, Marisol E Otero, Juul M P A Van den Reek, Elke M G J De Jong

Affiliation

¹ Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands. Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.. marloes.vanmuijen@radboudumc.nl.

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Double-Blind Method
Humans
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Severity of Illness Index
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
guselkumab